3Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 2003 ;107(3) :363-369.
4Ridker PM,Morrow D,MPH. High-sensitivity C-reaction protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol,2003 ;92(Suppl) :17-22.
5Zairis MN, Manousakis SJ, Stefanidis AS, et al. C-reactive protein and rapidly progressive coronary artery disease is there any relation ? Clin Cardiol, 2003; 26(2): 85 - 90.
6Eren E, Yilmaz N, Pence S, et al. Diagnostic value of C-reactive protein in patients with angiographically documented coronary heart disease. Acta Medica ( Hradec kralove), 2002; 45(4):155-160.
7Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Eng J Med, 2000; 342(12):836-843.
8Yamashita H,Shimada K,Seki E,et al. Concentrations of interleukins,interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardio,2003;91(2):133-136.
9Gomes MC. C-reactive protein:a new golden marker of cardiovascular risk. Rev Port Cardiol,2002 ;21(11):1329-1346.
10Nomoto K, Oguchi S, Watanabe I, et al. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-l. J Cardio, 2003;42(5):201-206.
